Literature DB >> 14597726

Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis.

Michael Frosch1, Thomas Vogl, Rüdiger Waldherr, Clemens Sorg, Cord Sunderkötter, Johannes Roth.   

Abstract

Expression of two S100 proteins, myeloid related protein (MRP)8 and MRP14, as well as their complex formation indicate proinflammatory properties of macrophages. We analyzed if the different forms of glomerulonephritis (GN) are associated with the appearance of certain phenotypes of infiltrating macrophages characterized by expression of MRP8 and MRP14 as well as their complex formation. Immunohistochemical analysis of 89 renal biopsies with different forms of nephritis revealed that expression and complex formation of MRP8 and MRP14 by infiltrating macrophages in the glomeruli correlated with the severity of the inflammatory process. As such, MRP8/MRP14-expressing monocytes prevailed in highly proliferating forms of GN, i.e., systemic lupus erythematosus GN and extracapillary GN. In contrast, a high percentage of macrophages in the renal interstitium expressed MRP8 and MRP14 without concomitant formation of their complex, and they indicated a chronic type of inflammatory reaction in GN. Immunosuppressive drugs had no direct effects on the expression of MRP8 and MRP14 in macrophages in vitro. The correlation of MRP8 and MRP14 expression with disease activity indicates that these calcium-binding proteins are of pathophysiological relevance in GN. In addition, our findings reflect differences in the inflammatory mechanisms underlying the various forms of GN, as they revealed that distinct macrophage subpopulations prevail in the different forms of GN.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597726     DOI: 10.1189/jlb.0203076

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  18 in total

Review 1.  Heme Oxygenase-1 in Kidney Health and Disease.

Authors:  Jeremie M Lever; Ravindra Boddu; James F George; Anupam Agarwal
Journal:  Antioxid Redox Signal       Date:  2016-05-26       Impact factor: 8.401

2.  Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss.

Authors:  Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Fernando Rotellar; Victor Valentí; Camilo Silva; María J Gil; José Manuel Fernández-Real; Javier Salvador; Gema Frühbeck
Journal:  Mol Med       Date:  2011-07-05       Impact factor: 6.354

Review 3.  The role of necrotic cell death in the pathogenesis of immune mediated nephropathies.

Authors:  Neelakshi R Jog; Roberto Caricchio
Journal:  Clin Immunol       Date:  2014-05-17       Impact factor: 3.969

Review 4.  Calprotectin in rheumatic diseases.

Authors:  Francesca Ometto; Lara Friso; Davide Astorri; Costantino Botsios; Bernd Raffeiner; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

5.  Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.

Authors:  K Matsumoto; N Maruyama; T Maruyama; Y Ohnishi; S Nonaka; A Inoshita; K Ito; S Kitajima; M Abe; A Satomura; T Fujita
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

6.  The role of serum myeloid-related protein 8/14 complex in Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki; Shinichirou Ohara; Yusaku Abe; Masahiro Watanabe; Kazuhide Suyama; Masatoki Sato; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

Review 7.  Dangers within: DAMP responses to damage and cell death in kidney disease.

Authors:  Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

8.  Carbon monoxide exposure improves immune function in lupus-prone mice.

Authors:  Juan P Mackern-Oberti; Carolina Llanos; Leandro J Carreño; Sebastián A Riquelme; Sergio H Jacobelli; Ignacio Anegon; Alexis M Kalergis
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

Review 9.  Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.

Authors:  R K Boyapati; A G Rossi; J Satsangi; G-T Ho
Journal:  Mucosal Immunol       Date:  2016-03-02       Impact factor: 7.313

10.  Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis.

Authors:  Ruth J Pepper; Sally Hamour; Konstantia-Maria Chavele; Sarah K Todd; Niels Rasmussen; Shaun Flint; Paul A Lyons; Kenneth G C Smith; Charles D Pusey; H Terence Cook; Alan D Salama
Journal:  Kidney Int       Date:  2013-02-20       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.